Allan H Smith1, Mohammad Yunus, Al Fazal Khan, Ayse Ercumen, Yan Yuan, Meera Hira Smith, Jane Liaw, John Balmes, Ondine von Ehrenstein, Rubhana Raqib, David Kalman, Dewan S Alam, Peter K Streatfield, Craig Steinmaus. 1. Arsenic Health Effects Research Program, School of Public Health, University of California, Berkeley, CA, USA, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh, Department of Medicine, University of California, San Francisco, CA, USA, Department of Community Health Sciences, Fielding School of Public Health, University of California, Los Angeles, CA, USA, Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, WA, USA and Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Oakland, CA, USA.
Abstract
BACKGROUND: Arsenic exposure via drinking water increases the risk of chronic respiratory disease in adults. However, information on pulmonary health effects in children after early life exposure is limited. METHODS: This population-based cohort study set in rural Matlab, Bangladesh, assessed lung function and respiratory symptoms of 650 children aged 7-17 years. Children with in utero and early life arsenic exposure were compared with children exposed to less than 10 µg/l in utero and throughout childhood. Because most children drank the same water as their mother had drunk during pregnancy, we could not assess only in utero or only childhood exposure. RESULTS: Children exposed in utero to more than 500 µg/l of arsenic were more than eight times more likely to report wheezing when not having a cold [odds ratio (OR) = 8.41, 95% confidence interval (CI): 1.66-42.6, P < 0.01] and more than three times more likely to report shortness of breath when walking on level ground (OR = 3.86, 95% CI: 1.09-13.7, P = 0.02) and when walking fast or climbing (OR = 3.19, 95% CI: 1.22-8.32, P < 0.01]. However, there was little evidence of reduced lung function in either exposure category. CONCLUSIONS: Children with high in utero and early life arsenic exposure had marked increases in several chronic respiratory symptoms, which could be due to in utero exposure or to early life exposure, or to both. Our findings suggest that arsenic in water has early pulmonary effects and that respiratory symptoms are a better marker of early life arsenic toxicity than changes in lung function measured by spirometry.
BACKGROUND:Arsenic exposure via drinking water increases the risk of chronic respiratory disease in adults. However, information on pulmonary health effects in children after early life exposure is limited. METHODS: This population-based cohort study set in rural Matlab, Bangladesh, assessed lung function and respiratory symptoms of 650 children aged 7-17 years. Children with in utero and early life arsenic exposure were compared with children exposed to less than 10 µg/l in utero and throughout childhood. Because most children drank the same water as their mother had drunk during pregnancy, we could not assess only in utero or only childhood exposure. RESULTS:Children exposed in utero to more than 500 µg/l of arsenic were more than eight times more likely to report wheezing when not having a cold [odds ratio (OR) = 8.41, 95% confidence interval (CI): 1.66-42.6, P < 0.01] and more than three times more likely to report shortness of breath when walking on level ground (OR = 3.86, 95% CI: 1.09-13.7, P = 0.02) and when walking fast or climbing (OR = 3.19, 95% CI: 1.22-8.32, P < 0.01]. However, there was little evidence of reduced lung function in either exposure category. CONCLUSIONS:Children with high in utero and early life arsenic exposure had marked increases in several chronic respiratory symptoms, which could be due to in utero exposure or to early life exposure, or to both. Our findings suggest that arsenic in water has early pulmonary effects and that respiratory symptoms are a better marker of early life arsenic toxicity than changes in lung function measured by spirometry.
Entities:
Keywords:
Arsenic; children; in utero; lung function; pulmonary; respiratory
Authors: Craig Steinmaus; Catterina Ferreccio; Johanna Acevedo; Yan Yuan; Jane Liaw; Viviana Durán; Susana Cuevas; José García; Rodrigo Meza; Rodrigo Valdés; Gustavo Valdés; Hugo Benítez; Vania VanderLinde; Vania Villagra; Kenneth P Cantor; Lee E Moore; Saida G Perez; Scott Steinmaus; Allan H Smith Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-05-23 Impact factor: 4.254
Authors: Anthony Nardone; Catterina Ferreccio; Johanna Acevedo; Wayne Enanoria; Alden Blair; Allan H Smith; John Balmes; Craig Steinmaus Journal: Environ Res Date: 2017-07-21 Impact factor: 6.498
Authors: Karen Bradham; Carina Herde; Paul Herde; Albert L Juhasz; Karen Herbin-Davis; Brittany Elek; Amy Farthing; Gary L Diamond; David J Thomas Journal: J Agric Food Chem Date: 2020-02-19 Impact factor: 5.279
Authors: Craig Steinmaus; Catterina Ferreccio; Yan Yuan; Johanna Acevedo; Francisca González; Liliana Perez; Sandra Cortés; John R Balmes; Jane Liaw; Allan H Smith Journal: Am J Epidemiol Date: 2014-11-04 Impact factor: 4.897
Authors: Taehyun Roh; Craig Steinmaus; Guillermo Marshall; Catterina Ferreccio; Jane Liaw; Allan H Smith Journal: Am J Epidemiol Date: 2018-11-01 Impact factor: 4.897